已收盘 08-14 16:00:00 美东时间
+0.270
+8.91%
绩优股普升!量子计算公司昆腾飙升64%,近三年来首度非GAAP单季盈利;NIQ劲升42%,Q2 EPS扭亏大幅增长;Fermi升逾21%,签署大规模AI数据中心长期租约>>
08-12 15:54
今日重点评级关注:Truist Securities:维持AbCellera Biologics"买入"评级,目标价从12美元升至30美元;Stifel:维持Proficient Auto Logistics"买入"评级,目标价从9美元升至12美元
08-12 08:45
BTIG analyst Sam Eiber maintains Neuronetics (NASDAQ:STIM) with a Buy and raises the price target from $5 to $6.
08-12 02:00
Neuronetics shares are trading higher after the company reported better-than-expected Q2 financial results.
08-11 21:17
Neuronetics (NASDAQ:STIM) narrows FY2026 sales outlook from $160.000 million-$166.000 million to $160.000 million-$164.000 million vs $161.125 million estimate.
08-11 19:59
Neuronetics (NASDAQ:STIM) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.13) by 58.33 percent. This is a 66.67 percent increase over losses of $(0.15) per share from the same period last year. The company reported quarterly sales of $41.568 million wh...
08-11 19:59
Neuronetics, Inc. and its second-largest shareholder, Jorey Chernett, have established a framework to align the company's Board of Directors, management, and Mr. Chernett. Chernett expresses confidence in the company's financial position and management's execution. He will have the opportunity to recommend a new Board member. The company's largest shareholder, Madryn Asset Management, reaffirms its belief in Neuronetics' long-term prospects. Neur...
08-03 12:00
Neuronetics, Inc. announced inducement awards, including restricted stock units (RSUs), to five new non-executive employees. The awards, granted under the 2020 Inducement Incentive Plan, vest over three to four years contingent on continued employment. Phillip McDaniel received 18,000 and 12,000 RSUs, Nicolas Jackson 9,000, Martin Webb 22,500 and 15,000, William Peschel 2,400, and Alex Vargas 2,400. Neuronetics is a leader in interventional menta...
07-31 21:00
AMC院线劲升26%,Q2财报超预期;IREN大涨19%,斩获28亿美元重磅AI云合同;ACHR升19%,携手Anduril进军军工领域>>
07-21 18:51
今日重点评级关注:Needham:维持Immuneering"买入"评级,目标价从11美元升至18美元;富瑞:维持塞德斯医疗"买入"评级,目标价从90美元升至100美元
07-21 11:36